基于生物活性的质量标志物:中药质量控制新策略
本文综述了中药质量评价体系,聚焦基于生物效应的质量标志物(Q-marker)及其在中药质量评价中的应用。作者提出整合生物效价与生物标志物的Q-biomarker概念,并优化了Q-marker的定义与属性。结论提出以与特定疾病相关的体内Q-biomarker作为中药质量评价新策略。
要点
- Q-marker需具备可量化、特异性及与生物效应相关等属性
- 整合生物效价与生物标志物可形成Q-biomarker评价策略
- 体内与特定疾病相关的Q-biomarker是中药质量评价新方向
核心结论
- 提出以与特定疾病相关的体内Q-biomarker作为中药质量评价的新策略。
- Q-biomarker质量评价体系可为中药标准化与全球化提供新视角。
研究设计与样本
- 本文为综述,检索并汇总了中药质量评价体系、基于生物效应的质量标志物及其应用的相关研究。
主要发现
- 既往研究已用生物效价和生物标志物评价中药质量,并提供了建立质量评价体系的新策略与方法。
- 作者整合生物效价与生物标志物,提出Q-biomarker用于中药质量评价。
- 作者依据中药质量评价需求,优化了Q-marker概念并总结其定义与属性(包括可量化、特异性及与生物响应相关)。
关键数值与推荐
- Q-marker属性包括可量化、特异性及与生物响应相关。
- 提出以体内与特定疾病相关的Q-biomarker作为质量评价策略。
临床怎么用
- 在中药质量控制中可考虑整合生物效价与生物标志物构建Q-biomarker评价指标。
- 选择与特定疾病相关的体内生物标志物作为质量评价依据。
局限性
- 原文为综述,未报告具体研究样本量、效应量或验证性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The quality and quality evaluation system of traditional Chinese medicine (TCM) are crucial in the safety and effectiveness assessment of TCM. However, they are also the major bottlenecks that restrict the quality control of TCM. Given the nature of Chinese medicine and the limitations of science and technology, the quality evaluation of TCM involves a few difficulties. Therefore, scholars have conducted considerable amount of research on this topic and obtained promising results. Biological potency and biomarkers have been used to evaluate the quality of TCM. Previous studies provided new strategies and methods to establish a system on quality evaluation. PURPOSE: This review aims to provide a new strategy for the quality control of Chinese herbal medicine by combining biological potency and biomarkers based on biological effects. METHODS: We reviewed the quality evaluation system of Chinese herbal medicine, focusing on quality markers (Q-markers) based on biological effects and the application of these markers in the quality evaluation of Chinese herbal medicine. We also reviewed the factors affecting quality, the difficulties related to the quality evaluation system and the attempt of researchers to improve the quality control of TCM. RESULTS: We propose Q-biomarkers by integration of biological potency and biomarkers to evaluate the quality of TCM. The quality markers provided us significant insights in the process of definition. We further optimised the concept of Q-markers and summarised their definition and properties (including quantification, specificity and related to biological response) in accordance with the requirement of the quality evaluation of TCM. CONCLUSION: We propose the use of Q-biomarkers in vivo related to specific diseases as a new strategy for the quality evaluation of Chinese herbal medicine. The quality evaluation system of Q-biomarkers would provide a new perspective to standardise and globalise TCM.
引用
- Wu X, Zhang H, Fan S, et al. Quality markers based on biological activity: A new strategy for the quality control of traditional Chinese medicine. Phytomedicine. 2018. PMID: 29506773. doi:10.1016/j.phymed.2018.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。